4.8 Article

Impaired eIF5A function causes a Mendelian disorder that is partially rescued in model systems by spermidine

Journal

NATURE COMMUNICATIONS
Volume 12, Issue 1, Pages -

Publisher

NATURE PORTFOLIO
DOI: 10.1038/s41467-021-21053-2

Keywords

-

Funding

  1. Health Innovation Challenge Fund [HICF-1009-003]
  2. Wellcome Trust
  3. Wellcome Trust Sanger Institute [WT098051]
  4. National Institute for Health Research, through the Comprehensive Clinical Research Network, UK
  5. CONICYT, Chile's National Commission for Scientific and Technological Research [72160007]
  6. Kabuki Research Fund at Manchester University NHS Foundation Trust
  7. Action Medical Research [GN2494]
  8. Manchester NIHR Biomedical Research Centre [IS-BRC-1215-20007]
  9. Biotechnology and Biological Sciences Research Council (BBSRC), UK [BB/N014049/1]
  10. Stroke Association (TSA LECT) [2017/02, NC/N002598/1]
  11. Agence Nationale de la Recherche [ANR-10-IAHU-01]
  12. MSDAvenir (DevoDecode project)
  13. BBSRC [BB/N014049/1, BB/S014667/1] Funding Source: UKRI

Ask authors/readers for more resources

The study uncovers the role of eIF5A in human development and disease, demonstrates the mechanistic complexity of EIF5A-related disorder, and raises possibilities for its treatment. Yeast and zebrafish experiments show that EIF5A variants cause a Mendelian disorder through reduced eIF5A-ribosome interactions, which can be partially corrected by spermidine supplementation.
The structure of proline prevents it from adopting an optimal position for rapid protein synthesis. Poly-proline-tract (PPT) associated ribosomal stalling is resolved by highly conserved eIF5A, the only protein to contain the amino acid hypusine. We show that de novo heterozygous EIF5A variants cause a disorder characterized by variable combinations of developmental delay, microcephaly, micrognathia and dysmorphism. Yeast growth assays, polysome profiling, total/hypusinated eIF5A levels and PPT-reporters studies reveal that the variants impair eIF5A function, reduce eIF5A-ribosome interactions and impair the synthesis of PPT-containing proteins. Supplementation with 1mM spermidine partially corrects the yeast growth defects, improves the polysome profiles and restores expression of PPT reporters. In zebrafish, knockdown eif5a partly recapitulates the human phenotype that can be rescued with 1 mu M spermidine supplementation. In summary, we uncover the role of eIF5A in human development and disease, demonstrate the mechanistic complexity of EIF5A-related disorder and raise possibilities for its treatment. eIF5A is critical for protein synthesis but has not yet been associated with congenital human disease. Here, the authors show that EIF5A variants cause a Mendelian disorder via reduced eIF5A-ribosome interactions and this phenotype is partially corrected by spermidine supplementation in yeast and zebrafish.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available